Medical Cannabis Has Passed Peak Hype and Is Moving Toward Realistic Clinical Application | Research

The takeaway

Framed through the Gartner Hype Cycle, medical cannabis has passed its peak of inflated expectations and is entering a phase of more selective, evidence-based use with modest but real clinical benefits.

Clinicians evaluating medical cannabis for patients; healthcare system administrators and policymakers.

Clinical benefits described as "generally modest" and dependent on product, dose, and population

What the researchers found

Medical cannabis research surged in the mid-to-late 2010s, but measured clinical benefits are generally modest, vary by product/dose/population, and are limited by research challenges including heterogeneity and blinding difficulties. The field is progressing from inflated expectations toward realistic therapeutic goals, standardized products, and systematic safety attention.

Why it matters

The hype cycle framework helps explain the whiplash many have experienced with medical cannabis -- from "miracle cure" enthusiasm to "it doesn't work" skepticism. Recognizing where the field is on this cycle allows for more productive conversations about realistic expectations and research priorities.

The numbers in context

Research output surged in mid-to-late 2010s. Clinical benefits described as generally modest and variable by product, dose, and population. Key barriers identified: lack of standardized products, limited head-to-head comparisons with existing therapies, inadequate blinding in trials.

How the study worked

Narrative review synthesizing clinical evidence on medical cannabis through the lens of the Gartner Hype Cycle technology adoption framework. Reviews therapeutic evidence, identifies current limitations, and proposes paths forward for the field.

What this study cannot tell us

The hype cycle is a descriptive framework, not a predictive model. Narrative reviews are inherently subject to author perspective. The field is evolving rapidly, and the review may not capture the most recent developments.

How to read the evidence

Moderate: thoughtful synthesis applying an established technology adoption framework to medical cannabis evidence, but narrative review without systematic methodology.

When this study was published

2025 review.

The bigger picture

Many breakthrough technologies and therapies follow the hype cycle pattern. The maturation of medical cannabis from overpromising to evidence-based application mirrors the trajectory of other medical innovations. The critical next steps are head-to-head trials against existing treatments and standardized products that enable reproducible research.

Questions still open

How long will the transition to the "Plateau of Productivity" take for medical cannabis? Will head-to-head trials against established therapies clarify or further complicate the evidence?

Common questions

What is the Hype Cycle?

The Gartner Hype Cycle describes how new technologies progress through stages: a Technology Trigger, Peak of Inflated Expectations, Trough of Disillusionment, Slope of Enlightenment, and finally a Plateau of Productivity where realistic applications emerge.

Does medical cannabis actually work?

The evidence suggests modest benefits for specific conditions and populations. The problem has been overpromising broad effectiveness. As the field matures, identifying which patients benefit most from which products at which doses will define its legitimate clinical role.

Read the original research

Medical cannabis and the hype cycle: Clinical evidence and future directions.

European journal of internal medicine, 106644

View on PubMed ↗Publisher’s paper ↗

Citation

Abuhasira, Ran; Novack, Victor. (2025). Medical cannabis and the hype cycle: Clinical evidence and future directions.. European journal of internal medicine, 106644. https://doi.org/10.1016/j.ejim.2025.106644